The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells.
Sign Up to like & getrecommendations! Published in 2019 at "F1000Research"
DOI: 10.12688/f1000research.19327.1
Abstract: Background: Pyocyanin (PCN), a highly pathogenic pigment produced by Pseudomonas aeruginosa, induces caspase 3-dependent human B cell (Raji cells) death. The aim of the present study, therefore, was to assess whether antigen-specific IgY antibodies may… read more here.
Keywords: raji; specific igy; antigen specific; raji cells ... See more keywords
Anticancer potential of methanolic extracts from Pleurotus species on raji cells and antibacterial activity against Methicillin-Resistant Staphylococcus aureus
Sign Up to like & getrecommendations! Published in 2020 at "Biodiversitas"
DOI: 10.13057/biodiv/d211221
Abstract: Abstract. Prastiyanto ME, Rukmana RM, Saraswati DK, Darmawati S, Maharani ETW, Tursinawati Y. 2020. Anticancer potential of methanolic extracts from Pleurotus species on raji cells and antibacterial activity against Methicillin-Resistant Staphylococcus aureus. Biodiversitas 21: 5644-5649.… read more here.
Keywords: methanolic extracts; activity methicillin; raji cells; antibacterial activity ... See more keywords
Emodin promotes the arrest of human lymphoma Raji cell proliferation through the UHRF1-DNMT3A-∆Np73 pathways
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2017.7423
Abstract: Emodin is an active constituent found in the roots and rhizomes of numerous Chinese medicinal herbs. It exerts antitumor activity against Dalton's lymphoma in vivo, although the detailed mechanisms by which emodin induces apoptosis remains… read more here.
Keywords: raji; lymphoma raji; raji cell; raji cells ... See more keywords
Camptothecin enhances 131I-rituximab-induced G1-arrest and apoptosis in Burkitt lymphoma cells
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Therapeutics"
DOI: 10.4103/jcrt.jcrt_1012_19
Abstract: Background: Rituximab is a chimeric monoclonal antibody against CD20. It is an established immunotherapeutic agent for non-Hodgkin's lymphoma. Even though rituximab has been used in clinics for decades, only 50% of the patients respond to… read more here.
Keywords: rituximab; 131i rituximab; apoptosis; raji cells ... See more keywords